Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of Apixaban standard dosing in underweight patients with non-valvular atrial fibrillation: a retrospective cohort study.
Sulaiman KA, Aljuhani O, Alkofide H, Aljohani MA, Badreldin HA, Al Harbi M, Aquil G, Alhajaji R, Alqahtani RA, Babonji A, Altuwayr M, Alshehri AA, Alfaifi M, Alharthi AF, Alzahrani M, Al Sulaiman T, Alqahtani N, Alshahrani WA, Al Katheri A, Albekairy AM. Sulaiman KA, et al. Among authors: alharthi af. Thromb J. 2024 May 22;22(1):43. doi: 10.1186/s12959-024-00613-8. Thromb J. 2024. PMID: 38778323 Free PMC article.
Evaluation of Low-Dose Aspirin use among Critically Ill Patients with COVID-19: A Multicenter Propensity Score Matched Study.
Al Harthi AF, Aljuhani O, Korayem GB, Altebainawi AF, Alenezi RS, Al Harbi S, Gramish J, Kensara R, Hafidh A, Al Enazi H, Alawad A, Alotaibi R, Alshehri A, Alhuthaili O, Vishwakarma R, Bin Saleh K, Alsulaiman T, Alqahtani RA, Hussain S, Almazrou S, Al Sulaiman K. Al Harthi AF, et al. J Intensive Care Med. 2022 Sep;37(9):1238-1249. doi: 10.1177/08850666221093229. Epub 2022 Apr 21. J Intensive Care Med. 2022. PMID: 35450493 Free PMC article.
Statins and Risk of Thrombosis in Critically ill Patients with COVID-19: A Multicenter Cohort Study.
Al Harbi S, Kensara R, Aljuhani O, Korayem GB, Altebainawi AF, Al Harthi A, Vishwakarma R, Alenazi AM, Almutairi A, Alshaya O, Alraddadi S, Al Sulaiman T, Aldakkan L, Mahboob R, Alaamer K, Alissa A, Hafiz A, Aldhayyan N, Althewaibi S, Alenezi F, Alkhotani NY, Alghamdi SA, Alenazi AA, Al Sulaiman K. Al Harbi S, et al. Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221103864. doi: 10.1177/10760296221103864. Clin Appl Thromb Hemost. 2022. PMID: 35658686 Free PMC article.
Early dexamethasone use as a protective measure in non-mechanically ventilated critically ill patients with COVID-19: a multicenter, cohort study.
Al Sulaiman K, Korayem GB, Eljaaly K, Altebainawi AF, Al Harbi O, Badreldin HA, Al Harthi A, Al Yousif G, Vishwakarma R, Albelwi S, Almutairi R, Almousa M, Alghamdi R, Alhubaishi A, Alissa A, Alharbi A, Algarni R, Al Homaid S, Al Qahtani K, Akhani N, Al Atassi A, Al Ghamdi G, Aljuhani O. Al Sulaiman K, et al. Sci Rep. 2022 Jun 13;12(1):9766. doi: 10.1038/s41598-022-13239-5. Sci Rep. 2022. PMID: 35697822 Free PMC article.
The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: A multicenter, cohort study.
Al Sulaiman K, Aljuhani O, Korayem GB, Altebainawi AF, Al Harbi S, Al Shaya A, Badreldin HA, Kensara R, Alharthi AF, Alghamdi J, Alawad A, Alotaibi R, Kharbosh A, Al Muqati H, Alhuwahmel A, Almusallam M, Albarrak G, Al Sulaihim I, Alanazi B, Al-Dosari BS, Vishwakarma R, Alsaeedi AS, Al Ghamdi G, Alkofide H, Al-Dorzi HM. Al Sulaiman K, et al. Among authors: alharthi af. Front Public Health. 2022 Aug 11;10:877944. doi: 10.3389/fpubh.2022.877944. eCollection 2022. Front Public Health. 2022. PMID: 36033795 Free PMC article.
Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study.
Al Sulaiman K, Korayem GB, Altebainawi AF, Al Harbi S, Alissa A, Alharthi A, Kensara R, Alfahed A, Vishwakarma R, Al Haji H, Almohaimid N, Al Zumai O, Alrubayan F, Asiri A, Alkahtani N, Alolayan A, Alsohimi S, Melibari N, Almagthali A, Aljahdali S, Alenazi AA, Alsaeedi AS, Al Ghamdi G, Al Faris O, Alqahtani J, Al Qahtani J, Alshammari KA, Alshammari KI, Aljuhani O. Al Sulaiman K, et al. Among authors: alharthi a. Crit Care. 2022 Oct 3;26(1):304. doi: 10.1186/s13054-022-04158-y. Crit Care. 2022. PMID: 36192801 Free PMC article.
Evaluation of Early Tocilizumab Effect on Multiorgan Dysfunction in Critically Ill Patients With COVID-19: A Propensity Score-Matched Study.
Aljuhani O, Korayem GB, Altebainawi AF, Al Harthi A, Badreldin HA, Alsalloum MA, Eljaaly K, Alharbi A, Aljehani R, Vishwakarma R, Alenazi AA, Alalawi M, Alissa A, Al Aamer K, Al Enazi H, Almusallam M, Alshehri A, Bukhari R, Alasmari G, AlQahtani MM, Al Shammari S, Alsulaymi HO, Al Sulaiman K. Aljuhani O, et al. J Intensive Care Med. 2023 Jun;38(6):534-543. doi: 10.1177/08850666221150886. Epub 2023 Jan 22. J Intensive Care Med. 2023. PMID: 36683420 Free PMC article.
The effect of oseltamivir use in critically ill patients with COVID-19: A multicenter propensity score-matched study.
Aljuhani O, Korayem GB, Altebainawi AF, Alotaibi MS, Alrakban NA, Ghoneim RH, Vishwakarma R, Al Shaya AI, Al Harbi S, Gramish J, Almutairi DM, Alqannam G, Alamri FF, Alharthi AF, Alfaifi M, Al Amer A, Alenazi AA, Bin Aydan N, Alalawi M, Al Sulaiman K. Aljuhani O, et al. Among authors: alharthi af. Saudi Pharm J. 2023 Jul;31(7):1210-1218. doi: 10.1016/j.jsps.2023.05.006. Epub 2023 May 23. Saudi Pharm J. 2023. PMID: 37256102 Free PMC article.
22 results